NET PROFIT (x1000 DKK)
EMPLOYEES
Faaborg Pharma A/S
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
2,034
|
2,020
|
37 |
Total assets |
18,252
|
18,317
|
14,652 |
Current assets |
11,963
|
11,115
|
8,506 |
Current liabilities |
2,230
|
9,433
|
8,420 |
Equity capital |
7,994
|
6,383
|
4,824 |
- share capital |
1,000
![]() |
1,000
![]() |
1,000 |
Employees (average) |
15
![]() |
15
![]() |
15 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
43.8%
|
34.8%
|
32.9% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) | |||
Current ratio |
536.5%
|
117.8%
|
101.0% |
Return on equity (ROE) |
25.4%
|
31.6%
|
0.8% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.